Researchers find hope in diabetes battle

Sep 16, 2006

Canadian researchers have found what they hope is a magic bullet in combating diabetes.

McMasters University scientists are crediting extra use by the commonly prescribed Rosiglitazone for the hope of cutting the diabetes epidemic in half, the Hamilton Spectator said.

Widely used to treat type 2 diabetes, Rosiglitazone has been found effective for those at highest risk because of genetics, age or obesity, making it what researchers call the first line of defense for diabetes.

The results of the $25 million study were presented Friday at the annual meeting of the European Association for the Study of Diabetes in Copenhagen.

Copyright 2006 by United Press International

Explore further: Analysis of spider venom reveals seven promising compounds with potential to relieve chronic pain

add to favorites email to friend print save as pdf

Related Stories

Brazil receives macaw pair from Germany

1 minute ago

A pair of endangered blue macaws of the kind made famous by the hit animated "Rio" movies arrived in Brazil from Germany on Tuesday as part of a drive to ensure the bird's survival.

Recommended for you

Study shows who benefits most from statins

8 hours ago

New research suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. Using a relatively straightforward genetic analysis, the researchers ...

How much overdetection is acceptable in cancer screening?

8 hours ago

People have highly variable views on how much overdetection is acceptable in cancer screening, finds a UK survey in The BMJ this week. The authors say invitations for screening "should include clear information on the li ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.